Affinia Therapeutics
Building the next generation of gene therapies
34 employees · est. 2019 · Waltham, United States
Coave Therapeutics is the older company (2019 vs 2014).
Side-by-Side Comparison
| Metric | Affinia Therapeutics | Coave Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2019 | 2014 older |
| Headquarters | ||
| Headquarters | Waltham, United States | Paris, France |
| Employees | ||
| Employees | 34 | 36 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Life Sciences |
| Funding Stage | ||
| Funding Stage | Series C | Grant |
| Total Funding | ||
| Total Funding | $210.00M | $79.10M |
| Funding Rounds | ||
| Funding Rounds | 4 | 7 |
| Services | ||
| Services | Development of gene therapies, Clinical trials for BAG3 DCM, AAV-based therapeutic solutions, Research and development in genetic diseases | Not tracked yet |
| Target Customers | ||
| Target Customers | Patients with rare genetic diseases, Healthcare providers specializing in cardiology and neurology, Research institutions focused on genetic medicine, Biotechnology investors | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Gene Therapy, AAV9 Delivery, Genetic Medicines, Rare Diseases, Central Nervous System Diseases, Muscle Diseases, Synthetic Biology, Systems Biology, High-throughput Screening, Capsid Engineering, Heart Disease Treatment, Innovative Vector Design, Therapeutic Genetic Payload, Rational Design | Gene Therapy, Ophthalmic Disorders, CNS Disorders, Rare Diseases, Clinical Stage Company, AAV-Ligand Conjugates Technology, ALIGATER Platform, Gene Transduction, Tissue Distribution, Unmet Medical Needs |
| Website | ||
| Website | affiniatx.com | coavetx.com |
About Affinia Therapeutics
Affinia Therapeutics, founded in 2019, is at the forefront of biotechnology, focusing on building the next generation of gene therapies. This United States-based company boasts a team with extensive experience in translating scientific discoveries into clinical realities, targeting the genetic roots...
About Coave Therapeutics
Coave Therapeutics, a clinical stage biotechnology company, is dedicated to developing life-changing gene therapies for rare ocular and central nervous system (CNS) diseases. The company leverages its innovative AAV-Ligand Conjugates platform (ALIGATER) to enable targeted delivery and enhanced gene...
We will tell you when either one moves
BounceWatch watches Affinia Therapeutics and Coave Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Affinia Therapeutics and Coave Therapeutics — by email.
Frequently Asked Questions
Compare Affinia Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Affinia Therapeutics on 15 Jun 2026, and Coave Therapeutics on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
